Status:
COMPLETED
A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Intervention
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
This is a pilot study to evaluate the feasibility of a mobile health exercise intervention (GO-EXCAP Mobile App) over 7 weeks in 25 patients with myeloid neoplasms receiving hypomethylating agents.
Detailed Description
Up to 98% of older patients with myeloid neoplasms experience physical function decline, fatigue, and mood disturbances. Mobile health exercise interventions are promising strategy to prevent physical...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age is greater than or equal to 60 years
- Have a diagnosis of MN
- Receiving outpatient chemotherapy (e.g., HMA)
- English speaking
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- No medical contraindications for exercise per oncologist
- Able to walk 4 meters as part of Short Physical Performance Battery measured walk (with or without assistive device)
- Able to provide informed consent
- Exclusion Criteria
- Platelet count of 10,000 per microliter or less in the most recent blood draw (due to risk of spontaneous bleeding) prior to transfusion (i.e., patients are allowed to enroll if their platelet count is 10,000 per microliter or less but is scheduled to receive transfusion the day of consent)
Exclusion
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04035499
Start Date
February 1 2020
End Date
October 31 2021
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642